ECOG-ACRIN EA6174 (Merkel Cell Carcinoma)
What is the Purpose of this Study?
-Either get the study drug, Pembrolizumab, after surgery, OR
-Be observed after surgery for up to 1 year (no study drug)
-Complete regular follow-up appointments with your doctor every 6 months for 5 years
Who Can Participate in this Study?
Adults with Merkel cell carcinoma (MCC).
What is Involved?
We are doing this study to learn if we can lower the chance of your cancer growing back by adding the study drug (Pembrolizumab) after your surgery.